PCI Pharma Services

BPO/Outsource Services · Philadelphia, PA · Founded 1991 · Privately Held (backing)

Provider of pharmaceutical contract development and manufacturing services intended to serve pharmaceutical and biotechnology companies worldwide. PCI Pharma Services is based in Philadelphia, PA and was founded in 1991. Its last reported valuation was $10 billion in Jul 2025. It has raised $1.5 billion across 1 recorded round; the latest was a private secondary transaction in Jul 2025.

Last reported valuation
$10.0B
Oct 2026
Priced at
—
Total raised
$1.5B
Last round
Secondary Transaction - Private
Jul 2025

Who backs PCI Pharma Services?

8 investors
InvestorType
Mubadala Investment CompanyOther
Blue Owl Capital—
Bain CapitalPE / buyout
Alberta Investment ManagementOther
Kohlberg & CompanyPE / buyout
5C Lending Partners Corp. BDC—
Paras Capital—
Partners Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PCI Pharma Services investors

8 investors are on record for PCI Pharma Services, including Mubadala Investment Company, Blue Owl Capital, Bain Capital and Alberta Investment Management. The private secondary transaction in Jul 2025 drew 3 investors.

Free account
More of PCI Pharma Services with a free account
  • ·Watch PCI Pharma Services: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like PCI Pharma Services in bpo/outsource services. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View